Delivery Order SPE2DB20D3304-SPE2DB25FW5F0

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,446.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Serevent Diskus 50 MCG 60S, a respiratory medication. The contract has a period of performance through October 17, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,833.16 firm fixed price delivery order is for the supply of Serevent Diskus 50 mcg, a specialty brand name medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corporation holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Cencora, Inc. The $1,360.80 firm fixed-price delivery order is for the supply of Serevent Diskus (60 doses), a medication used to treat asthma and chronic obstructive pulmonary disease. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of 4,564,545 units of Serevent Diskus 50 mcg 60s pharmaceutical product to the Defense Logistics Agency (DLA). The $2,496.24 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,607.42 firm fixed-price delivery order is for the supply of Serevent Diskus 50 mcg, a medication used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of July 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Serevent Diskus 50 mcg medication. The award, valued at $3,383.33, is a delivery order contract with a firm fixed price pricing type and a completion date of May 1, 2024. Amerisourcebergen Drug Corp's Corporate Office Division will fulfill this order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Serevent Diskus 50 mcg inhalers. The contract is a delivery order with a firm fixed price of $2,657.88 and an ultimate completion date of June 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,972.68 firm fixed-price contract is for the delivery of Serevent Diskus 50 mcg 60s, a respiratory medication. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical division,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,688.48 firm fixed-price delivery order is for the supply of SEREVENT DISKUS 50 MCG 60S, a medication used for the treatment of respiratory conditions. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,023.38 firm fixed price delivery order is for the supply of 60 units of Serevent Diskus 50 mcg, a prescription medication. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW5F0
    Delivery Order

This federal contract award, valued at $2,732.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Serevent Diskus 50 MCG 60S, a respiratory medication, with an ultimate completion date of January 29, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This specific contract award was not designated with any set-aside requirements, indicating open competition.

Generated 5/21/25, 10:06 AM